Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin and Low Dose Radiation in SCCHN
NCT00176267Phase 2Completed
- Start
- Sep 2002
- Primary completion
- Jan 2005
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
Phase 2, open-label, single-arm trial of Paclitaxel Micelles for Injection and carboplatin in squamous cell carcinoma of the head and neck (HNSCC). Primary endpoints: Response rate and Pathologic complete responses. Started Sep 2002; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00176267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176267.